Activated Clotting Time (ACT)
The Activated Clotting Time or ACT test is a rapid test used to monitor the effects of high dose or medium dose heparin in patients during surgery or other procedures that require intense anticoagulation measures, such as cardiac bypass surgery, cardiac angioplasty, and dialysis. It is ordered in situations where the partial thromboplastin time (PTT) test is not clinically useful, or when quick results are critical to the surgical procedure. The ACT is sometimes used, along with the prothrombin time (PT), to help determine whether a bleeding episode is due to excessive anticoagulation or depletion of coagulation factors.
The ACT is also used to determine the dose of protamine sulfate that should be administered in order to reverse the heparin effect upon completion of the surgical or interventional procedure. ACT levels may also be used to monitor heparin or direct thrombin inhibitor in patients with documented lupus anticoagulant. The ACT is performed by tube or cartridge methodology and is typically performed as a point-of-care test.
- To monitor heparin dose in a patient undergoing surgical intervention
- Evaluation of a patient’s heparin anticoagulation level
Prolonged in:
- Heparin therapy
- Direct thrombin inhibitor therapy
- Severe deficiency of clotting factors (except factors VII and XIII)
- Functional platelet disorders
- Afibrinogenemia
In general, the accepted goal during cardiopulmonary bypass surgery is to give anticoagulant dosage in order to reach an ACT time of 400–500 seconds. For carotid artery stenting, dialysis, and angioplasty, the optimal ACT is lower (250–300 seconds). Each procedure and hospital (physician) will define its own target for ACT values. These targets may also be test method specific.
70–180 seconds (method-specific)
Whole blood (no anticoagulant, draw into tubes containing an activator).
Special Instructions
If drawn from an indwelling catheter, the line must be flushed to remove any trace of heparin, as this will affect the test results. Testing is performed at the patient bedside as a point-of-care test.
- Catheter Cardiovasc Interv. 2005;65:330. [PMID: 15864806]
- Acta Anaesthesiol Scand. 2006;50:461. [PMID: 16548858]
- Am J Cardiol. 2006;97:1657. [PMID: 16728233]
- Perfusion. 2006;21:27. [PMID: 16485696]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757